Erik S. Welf

Erik S. Welf

Auto-generated profile, based on publicly available information

Erik S. Welf

UT Southwestern Medical Center

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2023 in Nature
Verified
Journal Article
Closed access
PDF file
AWAndrew D. Weems
Andrew D. Weems
EWErik S. Welf
Erik S. Welf
MDMeghan K. Driscoll
Meghan K. Driscoll
FZFelix Y. Zhou
Felix Y. Zhou
HMHanieh Mazloom-Farsibaf
Hanieh Mazloom-Farsibaf
GDGaudenz Danuser
Gaudenz Danuser

11 December 2020 in Developmental Cell
Verified
Journal Article
Closed access
EWErik S. Welf
Erik S. Welf
CMChristopher E. Miles
Christopher E. Miles
JHJaewon Huh
Jaewon Huh
ESEtai Sapoznik
Etai Sapoznik
JCJoseph Chi
Joseph Chi
GDGaudenz Danuser
Gaudenz Danuser

25 February 2019 in Nature Methods
Verified
Journal Article
Closed access
BCBo-Jui Chang
Bo-Jui Chang
MKMark Kittisopikul
Mark Kittisopikul
KDKevin M. Dean
Kevin M. Dean
PRPhilippe Roudot
Philippe Roudot
EWErik S. Welf
Erik S. Welf
RFReto Fiolka
Reto Fiolka

28 June 2021 in Nature Methods
Verified
Journal Article
Closed access
PDF file
BCBo-Jui Chang
Bo-Jui Chang
JMJames D. Manton
James D. Manton
ESEtai Sapoznik
Etai Sapoznik
TPTheresa Pohlkamp
Theresa Pohlkamp
TTTamara S. Terrones
Tamara S. Terrones
RFReto Fiolka
Reto Fiolka

28 May 2019 in BMC Cancer
Verified
Journal Article
Open access
PDF file
VMVasanth S. Murali
Vasanth S. Murali
BCBo-Jui Chang
Bo-Jui Chang
RFReto Fiolka
Reto Fiolka
GDGaudenz Danuser
Gaudenz Danuser
MCMurat Can Cobanoglu
Murat Can Cobanoglu
EWErik S. Welf
Erik S. Welf
Every biological experiment requires a choice of throughput balanced against physiological relevance. Most primary drug screens neglect critical parameters such as microenvironmental conditions, cell-cell heterogeneity, and specific readouts of cell fate for the sake of throughput. Here we describe a methodology to quantify proliferation and viability of single cells in 3D culture conditions by leveraging automated microscopy and image analysis to facilitate reliable and high-throughput measurements. We detail experimental conditions that can be adjusted to increase either throughput or robustness of the assay, and we provide a stand alone image analysis program for users who wish to implement this 3D drug screening assay in high throughput. We demonstrate this approach by evaluating a combination of RAF and MEK inhibitors on melanoma cells, showing that cells cultured in 3D collagen-based matrices are more sensitive than cells grown in 2D culture, and that cell proliferation is much more sensitive than cell viability. We also find that cells grown in 3D cultured spheroids exhibit equivalent sensitivity to single cells grown in 3D collagen, suggesting that for the case of melanoma, a 3D single cell model may be equally effective for drug identification as 3D spheroids models. The single cell resolution of this approach enables stratification of heterogeneous populations of cells into differentially responsive subtypes upon drug treatment, which we demonstrate by determining the effect of RAK/MEK inhibition on melanoma cells co-cultured with fibroblasts. Furthermore, we show that spheroids grown from single cells exhibit dramatic heterogeneity to drug response, suggesting that heritable drug resistance can arise stochastically in single cells but be retained by subsequent generations. In summary, image-based analysis renders cell fate detection robust, sensitive, and high-throughput, enabling cell fate evaluation of single cells in more complex microenvironmental conditions.

15 May 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
AZAssaf Zaritsky
Assaf Zaritsky
AJAndrew R. Jamieson
Andrew R. Jamieson
EWErik S. Welf
Erik S. Welf
ANAndres Nevarez
Andres Nevarez
JCJustin Cillay
Justin Cillay
GDGaudenz Danuser
Gaudenz Danuser
Deep convolutional neural networks have emerged as a powerful technique to identify hidden patterns in complex cell imaging data. However, these machine learning techniques are often criticized as uninterpretable “black-boxes” - lacking the ability to provide meaningful explanations for the cell properties that drive the machine’s prediction. Here, we demonstrate that the latent features extracted from label-free live cell images by an adversarial auto-encoding deep convolutional neural network capture subtle details of cell appearance that allow classification of melanoma cell states, including the metastatic efficiency of seven patient-derived xenograft models that reflect clinical outcome. Although trained exclusively on patient-derived xenograft models, the same classifier also predicted the metastatic efficiency of immortalized melanoma cell lines suggesting that the latent features capture properties that are specifically associated with the metastatic potential of a melanoma cell regardless of its origin. We used the autoencoder to generate “in-silico” cell images that amplified the cellular features driving the classifier of metastatic efficiency. These images unveiled pseudopodial extensions and increased light scattering as functional hallmarks of metastatic cells. We validated this interpretation by analyzing experimental image time-lapse sequences in which melanoma cells spontaneously transitioned between states indicative of low and high metastatic efficiency. Together, this data is an example of how the application of Artificial Intelligence supports the identification of processes that are essential for the execution of complex integrated cell functions but are too subtle to be identified by a human expert.